Crescent Capital BDC, Inc.
NASDAQ:CCAPAsset Management
-$0.06 today
- Market cap
- $365.51M
- Beta
- 0.57
- P/E (TTM)
- 27.5
- EPS (TTM)
- $0.41
- Dividend yield
- 11.93%
Volume 0.25M
Average 0.23M
CCAP Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Crescent Capital BDC, Inc.NASDAQ: CCAP
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CCAP compares with its peers on the latest reported figures
- CCAP's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CCAP, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
MSIFMSC Income Fund, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CCAP) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CCAP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 101.1M | 52.1M | 147.33M | 142.44M | 156.19M |
| Cost of Revenue | 16.17M | 28.93M | 54.88M | 58.93M | 34.33M |
| Gross Profit | 84.93M | 23.17M | 92.46M | 83.5M | 121.85M |
| Gross Margin | 84.0% | 44.5% | 62.8% | 58.6% | 78.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.87M | 4.49M | 4.95M | 5.21M | 6.27B |
| Operating Expenses | (2.35M) | 6.67M | 8.35M | 8.76M | 2.92M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 9.48M |
| EBITDA | 87.28M | 16.51M | 84.11M | 74.74M | 103.11M |
| EBITDA Margin | 86.3% | 31.7% | 57.1% | 52.5% | 66.0% |
| Operating Income | 87.28M | 16.51M | 84.11M | 74.74M | 118.93M |
| Operating Margin | 86.3% | 31.7% | 57.1% | 52.5% | 76.1% |
| Interest Income | 85.66M | 108.52M | 169.87M | 182.94M | 142.94B |
| Interest Expense | 16.17M | 28.93M | 54.88M | 58.93M | 57.44M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (82.74M) |
| Income Before Tax | 87.28M | 16.51M | 84.11M | 74.74M | 36.19M |
| Pre-Tax Margin | 86.3% | 31.7% | 57.1% | 52.5% | 23.2% |
| Income Tax Expense | 3.65M | 961K | 274K | 1.09M | 1.68M |
| Net Income | 83.63M | 15.54M | 83.84M | 73.65M | 34.51M |
| Net Margin | 82.7% | 29.8% | 56.9% | 51.7% | 22.1% |
| EPS (Basic) | 2.94 | 0.50 | 2.33 | 1.99 | 0.93 |
| EPS (Diluted) | 2.94 | 0.50 | 2.33 | 1.99 | 0.93 |
| Weighted Avg Shares | 28.48M | 30.89M | 35.93M | 37.06M | 37.04M |
| Weighted Avg Shares (Diluted) | 28.48M | 30.89M | 35.93M | 37.06M | 37.04M |
Crescent Capital BDC, Inc.
NASDAQ:CCAP
Intrinsic Alpha fair value
Locked
Current Price
$9.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.